Sign In
Buy ALLR
$1.58
-0.110 (-6.51%)
At Close: Jun 03, 2026
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
07:15am, Friday, 08'th Mar 2024
Boston (March 8, 2024) — Allarity Therapeutics, Inc. (“Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today reported fi
Allarity Therapeutics to Present at Biomarkers 2024
06:00am, Wednesday, 28'th Feb 2024
Boston (February 28, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer tre
Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor
06:00am, Tuesday, 12'th Dec 2023
Boston (December 12, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together
Why Is Allarity Therapeutics (ALLR) Stock Up 42% Today?
10:07am, Tuesday, 05'th Dec 2023
Allarity Therapeutics (NASDAQ: ALLR ) stock is taking off on Tuesday after the clinical-stage biopharmaceutical company released data from a Phase 2 clinical trial of stenoparib. That clinical trial s
Boston (December 5, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together
Allarity Therapeutics to Present at Biomarkers Europe 2023
07:00am, Monday, 02'nd Oct 2023
BOSTON , October 2, 2023 — Allarity Therapeutics, Inc. (Allarity or the Company) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-spe
CAMBRIDGE, MA / ACCESSWIRE / September 14, 2023 / Allarity Therapeutics (NASDAQ:ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therap
PLOS ONE Publishes Data on Allarity Therapeutics' DRP® Companion Diagnostic for Dovitinib
04:05pm, Wednesday, 30'th Aug 2023
- T he DRP ® -Dovitinib companion diagnostic demonstrated an ability to identify advanced renal cell carcinoma patients that have improved clinical benefit from dovitinib treatment , as compared to u
Top 5 Health Care Stocks That Could Blast Off In August - Biolase (NASDAQ:BIOL), Allarity Therapeutics (NASDAQ:ALLR)
07:52am, Friday, 04'th Aug 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?
02:12pm, Wednesday, 05'th Jul 2023
Shares of clinical-stage precision medicine company Allarity Therapeutics (NASDAQ: ALLR ) initially soared to a 60% gain for the midweek session before paring down gains to roughly 30%. Undergirding s
Why Is Allarity Therapeutics (ALLR) Stock Down 22% Today?
08:36am, Wednesday, 19'th Apr 2023
Allarity Therapeutics (NASDAQ: ALLR ) stock is falling hard on Wednesday after the clinical-stage pharmaceutical company launched a public offering. That public offering has the company selling up to
7 Sorry Pharma Stocks to Sell in April Before It's Too Late
06:30am, Sunday, 16'th Apr 2023
Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extreme, but investing
Allarity's stock falls after saying enrollment in two clinical trials is slow
08:34am, Tuesday, 28'th Mar 2023
Shares of Allarity Therapeutics Inc. ALLR, -4.51% plunged 17% in premarket trading on Tuesday after the company told investors that it's struggled to enroll enough patients in Phase 2 studies for Ixem
Allarity Therapeutics: 1:35 Reverse Stock Split Goes Into Effect
10:00am, Saturday, 25'th Mar 2023
Allarity Therapeutics announced that it intends to effect a reverse stock split of its common stock, at a ratio of 1 post-split share for every 35 pre-split shares. The post Allarity Therapeutics: 1:3
Why Is Allarity Therapeutics (ALLR) Stock Down 23% Today?
09:15am, Friday, 24'th Mar 2023
Allarity Therapeutics (NASDAQ: ALLR ) stock is sliding lower on Friday after announcing a reverse stock split. According to a press release, the company plans to enact a one-for-35 reverse stock spli
